Kazuhiko Kogawa
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kazuhiko Kogawa.
Immunology Letters | 2002
Kazuhiko Kogawa; Seiho Nagafuchi; Hitoshi Katsuta; Jun Kudoh; Sadafumi Tamiya; Yumiko Sakai; Nobuyoshi Shimizu; Mine Harada
The responsible gene for autoimmune polyglandular syndrome type 1, known as autoimmune regulator (AIRE), was identified by positional cloning. The AIRE gene was reported to be expressed in the thymus medulla and lymph nodes. However, an expression of the AIRE gene in peripheral blood cells has not yet been reported. In the present study, we found that the AIRE gene was restrictively expressed in peripheral CD14-positive monocytes but not in CD4-positive T cells nor polymorphonuclear cells, as assessed by RT-PCR. Moreover, immunocytochemical study revealed the expression of the AIRE protein not only in CD14-positive monocytes but also in differentiated dendritic cells, cultured in RPMI1640 medium containing 800 U/ml GM-CSF, 1000 U/ml IL-4 and 100 U/ml TNF-alpha. Thus, it was concluded that the AIRE gene is restrictively expressed in the peripheral monocyte/dendritic cell lineage.
The FASEB Journal | 2003
Jiro Umeda; Shigetoshi Sano; Kazuhiko Kogawa; Noboru Motoyama; Kunihiko Yoshikawa; Satoshi Itami; Gen Kondoh; Takeshi Watanabe; Junji Takeda
To investigate the function of Bcl‐xL in the skin, we established keratinocyte‐specific Bcl‐x gene‐targeted mice under the keratin 5 promoter (K5). K5.Bcl‐xL– / – mice were viable, devoid of alteration in the development of skin or appendages. However, they harbored spontaneous apoptotic keratinocytes in the epidermis. Bcl‐xL‐deficient keratinocytes cultured in vitro readily underwent apoptosis in the absence of growth factors, but the addition of HGF or EGF resulted in restoration of cell survival, which was reversed by treatment with wortmannin, an inhibitor of phosphoinositide‐3 kinase (PI3K). Topical treatment of K5.Bcl‐xL− / − mice with wortmannin sensitized the skin for apoptosis induced by UV (UV) B, although wild‐type epidermis was only marginally affected by this treatment, suggesting that the resistance to UVB largely depended on PI3K‐Akt signaling in Bcl‐xL‐deficient mice but not in wild‐type mice. Furthermore, UVB irradiation resulted in redistribution of phosphorylated Akt from the basal layer to the suprabasal layer, indicating that Akt could spatially cooperate with Bcl‐xL upon UVB exposure in the upper epidermis where Bcl‐xL is normally localized. These results suggest that Bcl‐xL and the PI3K‐Akt pathway form a cooperative, intercompensatory axis for the protection of epidermal keratinocytes from apoptosis in vivo.
FEBS Letters | 1999
Seiho Nagafuchi; Hitoshi Katsuta; Kazuhiko Kogawa; Tomoyuki Akashi; Shiori Kondo; Yumiko Sakai; Tadasuke Tsukiyama; Daisuke Kitamura; Yoshiyuki Niho; Takeshi Watanabe
A non‐obese diabetic (NOD) mouse‐derived embryonic stem (ES) cell line has been stably maintained in an undifferentiated state with a characteristic ES cell‐like morphology, expressing the stem cell marker alkaline phosphatase, and displaying a normal diploid karyotype. After injecting the NOD‐ES cells into blastocysts, chimeric mice were obtained. Small but significant numbers of lymphocytes expressed the NOD‐derived MHC allele. When a chimeric mouse was mated with C57BL/6 mice, an agouti mouse was obtained, having the NOD‐derived H‐2 I‐Aβ g7 haplotype. Thus, an NOD‐ES cell line which can differentiate into lymphocytes with potential for germ line transmission was successfully established.
Microbiology and Immunology | 2006
Seiho Nagafuchi; Hitoshi Katsuta; Rimiko Koyanagi-Katsuta; Satoshi Yamasaki; Yasushi Inoue; Kazuya Shimoda; Yukari Ikeda; Mieko Shindo; Eiko Yoshida; Tomohito Matsuo; Yuju Ohno; Kazuhiko Kogawa; Keizo Anzai; Hironori Kurisaki; Jun Kudoh; Mine Harada; Nobuyoshi Shimizu
The autoimmune regulator (AIRE) gene is a gene responsible for autoimmune polyendocrinopathy‐candidiasis‐ectodermal dystrophy. Here we show that AIRE is expressed in human peripheral CD4‐positive T‐cells, and most highly in antigen‐ and interleukin 2‐stimulated T (IL‐2T) cells. Mitogen‐activated protein kinases (MAPKs), including MAPK kinase (MEK) 1/2 and p38 MAPK, were phosphorylated in IL‐2T cells and the expression of the AIRE gene was inhibited by a specific p38 MAPK inhibitor (SB203580), thereby indicating that AIRE gene expression is controlled by the MAPK pathway in IL‐2T cells. These data suggested the possible significance of the AIRE gene in the peripheral immune system.
EBioMedicine | 2015
Seiho Nagafuchi; Yumi Kamada-Hibio; Kanako Hirakawa; Nobutaka Tsutsu; Masae Minami; Akira Okada; Katsuya Kai; Miho Teshima; Arisa Moroishi; Yoshikazu Murakami; Yoshikazu Umeno; Yasushi Yokogawa; Kazuhiko Kogawa; Kenichi Izumi; Keizo Anzai; Ryuichi Iwakiri; Kazuyuki Hamaguchi; Nobuhiro Sasaki; Sakae Nohara; Eiko Yoshida; Mine Harada; Koichi Akashi; Toshihiko Yanase; Junko Ono; Toshimitsu Okeda; Ryoji Fujimoto; Kenji Ihara; Toshiro Hara; Masanori Iwase; Takanari Kitazono
Background Recently, natural mutation of Tyrosine kinase 2 (Tyk2) gene has been shown to determine susceptibility to murine virus-induced diabetes. In addition, a previous human genome-wide study suggested the type 1 diabetes (T1D) susceptibility region to be 19p13, where the human TYK2 gene is located (19p13.2). Methods Polymorphisms of TYK2 gene at the promoter region and exons were studied among 331 healthy controls, and 302 patients with T1D and 314 with type 2 diabetes (T2D) in the Japanese. Findings A TYK2 promoter haplotype with multiple genetic polymorphisms, which are in complete linkage disequilibrium, named TYK2 promoter variant, presenting decreased promoter activity, is associated with an increased risk of not only T1D (odds ratio (OR), 2.4; 95% confidence interval (CI), 1.2 to 4.6; P = 0.01), but also T2D (OR, 2.1; 95% CI, 1.1 to 4.1; P = 0.03). The risk is high in patients with T1D associated with flu-like syndrome at diabetes onset and also those without anti-glutamic acid decarboxylase autoantibody. Interpretation The TYK2 promoter variant is associated with an overall risk for diabetes, serving a good candidate as a virus-induced diabetes susceptibility gene in humans. Funding Ministry of Education, Culture, Sports, Science and Technology and of Health, Labor and Welfare of Japan.
Clinical Immunology | 2002
Kazuhiko Kogawa; Jun Kudoh; Seiho Nagafuchi; Shouichi Ohga; Hitoshi Katsuta; Hiromi Ishibashi; Mine Harada; Toshiro Hara; Nobuyoshi Shimizu
Internal Medicine | 2011
Masaro Ogimoto; Keizo Anzai; Hiromasa Takenoshita; Kazuhiko Kogawa; Yuko Akehi; Ryoko Yoshida; Makiko Nakano; Kunihiro Yoshida; Junko Ono
Immunology Letters | 2005
Seiho Nagafuchi; Hitoshi Katsuta; Yuju Ohno; Yasushi Inoue; Kazuya Shimoda; Kazuhiko Kogawa; Yukari Ikeda; Rimiko Koyanagi-Katsuta; Satoshi Yamasaki; Hiroyuki Tominaga; Sadafumi Tamiya; Tsukuru Umemura; Takeshi Otsuka; Toshihiro Miyamoto; Teruhisa Otsuka; Mine Harada; Jun Kudoh; Nobuyoshi Shimizu
Diabetes Care | 2005
Kenzo Iino; Takuko Fukui; Keizo Anzai; Masanori Iwase; Kazuhiko Kogawa; Masaro Ogimoto; Junko Ono; Takashi Asano; Mitsuo Iida; Kazuo Tamura
International Heart Journal | 2006
Yumiko Sakai; Toru Maruyama; Hitoshi Katsuta; Kazuhiko Kogawa; Tomoyuki Akashi; Ken Ichi Izumi; Hiroyuki Tominaga; Suminori Kono; Seiho Nagafuchi; Mine Harada